G. Addolorato, L. Leggio, A. Ferrulli, S. Cardone, G. Bedogni et al., Dose-Response Effect of Baclofen in Reducing Daily Alcohol Intake in Alcohol Dependence: Secondary Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial, Alcohol and Alcoholism, vol.46, issue.3, pp.312-319, 2011.
DOI : 10.1093/alcalc/agr017

S. Guérin, A. Laplanche, A. Dunant, and C. Hill, Alcohol-attributable mortality in France, The European Journal of Public Health, vol.23, issue.4, pp.588-93, 2013.
DOI : 10.1093/eurpub/ckt015

L. Leggio, J. Garbutt, and G. Addolorato, Effectiveness and Safety of Baclofen in the Treatment of Alcohol Dependent Patients, CNS & Neurological Disorders - Drug Targets, vol.9, issue.1, pp.33-44, 2010.
DOI : 10.2174/187152710790966614

B. Johnson, Update on neuropharmacological treatments for alcoholism: Scientific basis and clinical findings, Biochemical Pharmacology, vol.75, issue.1, pp.34-56, 2008.
DOI : 10.1016/j.bcp.2007.08.005

O. Ameisen, D. Beaurepaire, and R. , Suppression de la d??pendance ?? l???alcool et de la consommation d???alcool par le baclof??ne ?? haute dose??: un essai en ouvert, Annales M??dico-psychologiques, revue psychiatrique, vol.168, issue.2, pp.159-62, 2010.
DOI : 10.1016/j.amp.2009.12.008

G. Addolorato, L. Leggio, A. Ferrulli, S. Cardone, L. Vonghia et al., Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study, The Lancet, vol.370, issue.9603, pp.1915-1937, 2007.
DOI : 10.1016/S0140-6736(07)61814-5

R. Spanagel, V. Vengeliene, B. Jandeleit, W. Fischer, K. Grindstaff et al., Acamprosate Produces Its Anti-Relapse Effects Via Calcium, Neuropsychopharmacology, vol.231, issue.4, pp.783-91, 2014.
DOI : 10.1038/npp.2013.264

L. Leggio, A. Ferrulli, A. Zambon, F. Caputo, G. Kenna et al., Baclofen promotes alcohol abstinence in alcohol dependent cirrhotic patients with hepatitis C virus (HCV) infection, Addictive Behaviors, vol.37, issue.4, pp.561-565, 2012.
DOI : 10.1016/j.addbeh.2011.12.010

J. Brennan, J. Leung, J. Gagliardi, S. Rivelli, and A. Muzyk, Clinical effectiveness of baclofen for the treatment of alcohol dependence: a review, Clin Pharmacol Adv Appl, vol.5, pp.99-107, 2013.

B. Flannery, J. Garbutt, M. Cody, W. Renn, K. Grace et al., Baclofen for Alcohol Dependence: A Preliminary Open-Label Study, Alcoholism: Clinical & Experimental Research, vol.12, issue.10, pp.1517-1540, 2004.
DOI : 10.1111/j.1360-0443.1989.tb00737.x

G. Addolorato, F. Caputo, E. Capristo, G. Colombo, G. Gessa et al., Ability of baclofen in reducing alcohol craving and intake: II--Preliminary clinical evidence, Alcohol Clin Exp Res, vol.24, issue.1, pp.67-71, 2000.

P. Gache, Baclofène : vérités et promesses d'un « nouveau » venu dans le traitement de l'alcoolodépendance, Alcoologie Addictologie, vol.32, issue.2, pp.119-143, 2010.

S. Tiffany and J. Wray, The clinical significance of drug craving, Annals of the New York Academy of Sciences, vol.79, issue.Suppl. 1, pp.1-17, 2012.
DOI : 10.1111/j.1749-6632.2011.06298.x

G. Addolorato, F. Caputo, E. Capristo, M. Domenicali, M. Bernardi et al., BACLOFEN EFFICACY IN REDUCING ALCOHOL CRAVING AND INTAKE: A PRELIMINARY DOUBLE-BLIND RANDOMIZED CONTROLLED STUDY, Alcohol and Alcoholism, vol.37, issue.5, pp.504-512, 2002.
DOI : 10.1093/alcalc/37.5.504

J. Garbutt, A. Kampov-polevoy, R. Gallop, L. Kalka-juhl, and B. Flannery, Efficacy and Safety of Baclofen for Alcohol Dependence: A Randomized, Double-Blind, Placebo-Controlled Trial, Alcoholism: Clinical and Experimental Research, vol.12, issue.11, pp.1849-57, 2010.
DOI : 10.1111/j.1530-0277.2010.01273.x

L. Rigal, C. Alexandre-dubroeucq, R. De-beaurepaire, L. Jeunne, C. Jaury et al., Abstinence and 'Low-Risk' Consumption 1 Year after the Initiation of High-Dose Baclofen: A Retrospective Study among 'High-Risk' Drinkers, Alcohol and Alcoholism, vol.47, issue.4, pp.439-481, 2012.
DOI : 10.1093/alcalc/ags028

B. Grant, F. Stinson, D. Dawson, S. Chou, M. Dufour et al., Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions, Arch Gen Psychiatry, issue.8, pp.61807-61823, 2004.

J. Liu and L. Wang, Baclofen for alcohol withdrawal, Cochrane Database Syst Rev, vol.2, p.8502, 2013.

C. Villier, F. Sam-laï, N. Mallaret, and M. , Effets indésirables du baclofène dans le traitement des addictions. Suivi national de pharmacovigilance : année 2012, Comité technique de pharmacovigilance du 16 avril 2013, CT N°012013023. Commandité par l'ANSM

B. Rolland, S. Deheul, T. Danel, R. Bordet, and O. Cottencin, Un dispositif de prescriptions hors-AMM : exemple du baclof??ne, Th??rapie, vol.65, issue.6, pp.511-519, 2010.
DOI : 10.2515/therapie/2010073

P. Saviuc, Cas d'exposition au baclofène : données des centres antipoison et de toxicovigilance, 2003.

N. Leung, I. Whyte, and G. Isbister, Baclofen overdose: Defining the spectrum of toxicity, Emergency Medicine Australasia, vol.35, issue.1, pp.77-82, 2006.
DOI : 10.1016/S0196-0644(03)00600-0

F. Paille and L. Malet, Baclofène et alcool. Société française d'alcoologie, 2011.

S. Evans and A. Bisaga, Acute Interaction of Baclofen in Combination With Alcohol in Heavy Social Drinkers, Alcoholism: Clinical and Experimental Research, vol.33, issue.1, pp.19-30, 2009.
DOI : 10.1111/j.1530-0277.2008.00805.x

M. Farges and A. Haulotte, Caractérisation de la prescription et des effets du baclofène (Liorésal®), 2011.

O. Sanglade and . Baclofène, Intérêts et limites à partir de 13 entretiens qualitatifs. Thèse présentée pour le diplôme d'état de docteur en médecine, 2011.

A. Potgieter, F. Deckers, and P. Geerlings, Craving and relapse measurement in alcoholism., Alcohol and Alcoholism, vol.34, issue.2, pp.254-60, 1999.
DOI : 10.1093/alcalc/34.2.254

I. Bjelland, A. Dahl, T. Haug, and D. Neckelmann, The validity of the Hospital Anxiety and Depression Scale, Journal of Psychosomatic Research, vol.52, issue.2, pp.69-77, 2002.
DOI : 10.1016/S0022-3999(01)00296-3

A. Mcpherson and C. Martin, A narrative review of the Beck Depression Inventory (BDI) and implications for its use in an alcohol-dependent population, Journal of Psychiatric and Mental Health Nursing, vol.60, issue.1, pp.19-30, 2010.
DOI : 10.1111/j.1365-2850.2009.01469.x

N. Cazenave, Profils de personnalité, états émotionnels et prise de risques chez les femmes, Thèse de doctorat en psychologie du sport, 2006.

H. Dupont, Evaluation Dimensionnelle de l'impulsivité dans le trouble obsessionnel compulsif, Thèse de doctorat en psychologie cognitive. Université Lumière Lyon, 2002.

M. Johns, A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale, Sleep, vol.14, issue.6, pp.540-545, 1991.
DOI : 10.1093/sleep/14.6.540

N. Dussere, Efficacité du baclofène dans la stratégie de réduction des risques chez les patients alcoolo-dépendants, revue de la littérature et étude sur 81 patients suivis pendant 6 mois en ambulatoire. Thèse présentée pour le diplôme d'état de docteur en médecine, 2013.

L. Leggio, W. Zywiak, J. Mcgeary, S. Edwards, S. Fricchione et al., A human laboratory pilot study with baclofen in alcoholic individuals, Pharmacology Biochemistry and Behavior, vol.103, issue.4, pp.784-91, 2013.
DOI : 10.1016/j.pbb.2012.11.013

D. Moak, R. Anton, and P. Latham, Further Validation of the Obsessive-Compulsive Drinking Scale (OCDS): Relationship to Alcoholism Severity, American Journal on Addictions, vol.7, issue.1, pp.14-23, 1998.
DOI : 10.3109/10550499809034708

G. Dore, K. Lo, L. Juckes, S. Bezyan, and N. Latt, Clinical Experience with Baclofen in the Management of Alcohol-Dependent Patients with Psychiatric Comorbidity: A Selected Case Series, Alcohol and Alcoholism, vol.46, issue.6, pp.714-734, 2011.
DOI : 10.1093/alcalc/agr131

O. Ameisen, COMPLETE AND PROLONGED SUPPRESSION OF SYMPTOMS AND CONSEQUENCES OF ALCOHOL-DEPENDENCE USING HIGH-DOSE BACLOFEN: A SELF-CASE REPORT OF A PHYSICIAN, Alcohol and Alcoholism, vol.40, issue.2, pp.147-50, 2005.
DOI : 10.1093/alcalc/agh130

A. Pastor, D. Jones, and J. Currie, High-Dose Baclofen for Treatment-Resistant Alcohol Dependence, Journal of Clinical Psychopharmacology, vol.32, issue.2, pp.266-274, 2012.
DOI : 10.1097/JCP.0b013e31824929b2

C. Alexandre-dubroeucq, Alcool et baclofène : Etude sur 132 patients suivis pendant un an en ambulatoire. Thèse présentée pour le diplôme d'état de docteur en médecine, 2011.

J. Dupouy, J. Fournier, É. Jouanjus, A. Palmaro, J. Poutrain et al., Baclofen for alcohol dependence in France: Incidence of treated patients and prescription patterns???A cohort study, European Neuropsychopharmacology, vol.24, issue.2, pp.192-201, 2014.
DOI : 10.1016/j.euroneuro.2013.09.008

J. Garbutt and B. Flannery, Baclofen for alcoholism, The Lancet, vol.370, issue.9603, pp.1884-1889, 2007.
DOI : 10.1016/S0140-6736(07)61789-9

R. Anton, D. Moak, and P. Latham, The Obsessive Compulsive Drinking Scale, Archives of General Psychiatry, vol.53, issue.3, pp.225-256, 1996.
DOI : 10.1001/archpsyc.1996.01830030047008

G. Addolorato, L. Leggio, S. Cardone, A. Ferrulli, and G. Gasbarrini, Role of the GABAB receptor system in alcoholism and stress: focus on clinical studies and treatment perspectives, Alcohol, vol.43, issue.7, pp.559-63, 2009.
DOI : 10.1016/j.alcohol.2009.09.031

M. Lee, J. Bollinger, and L. Leggio, Increased Ethanol Consumption Following Chronic Psychosocial Stress: Do Oxytocin and Baclofen Hold any Therapeutic Promise?, Frontiers in Psychiatry, vol.4, p.148, 2013.
DOI : 10.3389/fpsyt.2013.00148

E. Krupitsky, A. Burakov, V. Ivanov, G. Krandashova, I. Lapin et al., Baclofen administration for the treatment of affective disorders in alcoholic patients, Drug and Alcohol Dependence, vol.33, issue.2, pp.157-63, 1993.
DOI : 10.1016/0376-8716(93)90057-W

J. Chick and D. Nutt, Substitution therapy for alcoholism: time for a reappraisal?, Journal of Psychopharmacology, vol.23, issue.8294, pp.205-217, 2012.
DOI : 10.1177/0269881111408463

B. Fleury, Patient alcoolodépendant : sevrage et accompagnement post sevrage. Service d'hépatogastroentérologie et d'alcoologie du CHU de Bordeaux

G. Addolorato and L. Leggio, Safety and Efficacy of Baclofen in the Treatment of Alcohol-Dependent Patients, Current Pharmaceutical Design, vol.16, issue.19, pp.2113-2120, 2010.
DOI : 10.2174/138161210791516440

C. Villier, E. Schir, and M. Mallaret, Effets indésirables du baclofène dans le traitement des addictions, Suivi national de Pharmacovigilance : année 2011. Comité technique de Pharmacovigilance de mars 2012. Commandité par l'ANSM

A. Marsot, B. Imbert, J. Alvarez, S. Grassin-delyle, I. Jaquet et al., High Variability in the Exposure of Baclofen in Alcohol-Dependent Patients, Alcoholism: Clinical and Experimental Research, vol.12, issue.2, pp.316-337, 2014.
DOI : 10.1111/acer.12235